SCHEMBL6985397

SCHEMBL6985397

CCOC(=O)C(Nc1ccc2c(c1)CCCN2C(=O)CCc1ccc(C#N)cc1)C(=O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA9 Q16790 2/20 0.42
ALDH1A1 P00352 3/20 0.41
TP53 P04637 2/20 0.41
RAB9A P51151 2/20 0.40
FPR1 P21462 2/20 0.40
FPR2 P25090 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
GAA P10253 1/20 0.39
PARP1 P09874 1/20 0.38
LMNA P02545 2/20 0.38
MAPT P10636 2/20 0.38
POLB P06746 1/20 0.38
NPC1 O15118 1/20 0.38
MAPK1 P28482 1/20 0.38
NR3C1 P04150 1/20 0.38
HPGD P15428 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6977731 0.82 TP53 (0.45) ALDH1A1TP53RAB9AFPR1FPR2
SCHEMBL6985377 0.81 RAB9A (0.62) ALDH1A1TP53RAB9AFPR1FPR2
SCHEMBL6985394 0.81 ALDH1A1 (0.41) ALDH1A1TP53RAB9AFPR1FPR2
SCHEMBL6976282 0.81 TP53 (0.44) ALDH1A1TP53RAB9AFPR1FPR2
SCHEMBL6981983 0.80 RAB9A (0.46) ALDH1A1TP53RAB9AFPR1FPR2
SCHEMBL6986432 0.79 TP53 (0.48) ALDH1A1TP53RAB9AFPR1FPR2
SCHEMBL6984100 0.79 TP53 (0.41) ALDH1A1TP53RAB9AFPR1FPR2
SCHEMBL6976631 0.78 HSD17B3 (0.46) ALDH1A1TP53RAB9AFPR1FPR2
SCHEMBL6986003 0.78 RAB9A (0.48) ALDH1A1TP53RAB9AFPR1FPR2
SCHEMBL6983653 0.78 FPR1 (0.44) ALDH1A1TP53RAB9AFPR1FPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed